These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1316824

  • 1. Age and beta-adrenergic receptor sensitivity to S(-)- and R,S(+/-)-propranolol in humans.
    Colangelo PM, Blouin RA, Steinmetz JE, McNamara PJ, DeMaria AN, Wedlund PJ.
    Clin Pharmacol Ther; 1992 May; 51(5):549-54. PubMed ID: 1316824
    [Abstract] [Full Text] [Related]

  • 2. Altered beta-adrenergic sensitivity and protein binding to 1-propranolol in the elderly.
    Tenero DM, Bottorff MB, Burlew BS, Williams JB, Lalonde RL.
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):702-7. PubMed ID: 1703590
    [Abstract] [Full Text] [Related]

  • 3. Reduced beta-adrenoceptor sensitivity in the elderly.
    Vestal RE, Wood AJ, Shand DG.
    Clin Pharmacol Ther; 1979 Aug; 26(2):181-6. PubMed ID: 37014
    [Abstract] [Full Text] [Related]

  • 4. [Changes in beta-adrenergic regulation of the cardiovascular system during aging].
    Korkushko OV.
    Fiziol Zh (1978); 1990 Aug; 36(5):104-11. PubMed ID: 2176987
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Beta-adrenergic receptors in the elderly are not less sensitive to timolol.
    Klein C, Gerber JG, Gal J, Nies AS.
    Clin Pharmacol Ther; 1986 Aug; 40(2):161-4. PubMed ID: 3015473
    [Abstract] [Full Text] [Related]

  • 7. Racemic (R,S)-propranolol versus half-dosed optically pure (S)-propranolol in humans at steady state: Hemodynamic effects, plasma concentrations, and influence on thyroid hormone levels.
    Stoschitzky K, Lindner W, Egginger G, Brunner F, Obermayer-Pietsch B, Passath A, Klein W.
    Clin Pharmacol Ther; 1992 Apr; 51(4):445-53. PubMed ID: 1563214
    [Abstract] [Full Text] [Related]

  • 8. Age and propranolol stereoselective disposition in humans.
    Colangelo PM, Blouin RA, Steinmetz JE, McNamara PJ, DeMaria AN, Wedlund PJ.
    Clin Pharmacol Ther; 1992 May; 51(5):489-94. PubMed ID: 1587061
    [Abstract] [Full Text] [Related]

  • 9. Exercise increases plasma concentrations of (R)- and (S)-propranolol.
    Stoschitzky K, Schumacher M, Stark G, Dimai HP, Stauber R, Stoschitzky P, Krejs GJ, Klein W, Lindner W.
    Eur J Clin Pharmacol; 1996 May; 50(4):339-42. PubMed ID: 8803530
    [Abstract] [Full Text] [Related]

  • 10. The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers.
    Daul A, Hermes U, Schäfers RF, Wenzel R, von Birgelen C, Brodde OE.
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):140-8. PubMed ID: 7599912
    [Abstract] [Full Text] [Related]

  • 11. Interindividual differences in beta-receptor density contribute to variability in response to beta-adrenoceptor antagonists.
    Zhou HH, Silberstein DJ, Koshakji RP, Wood AJ.
    Clin Pharmacol Ther; 1989 Jun; 45(6):587-92. PubMed ID: 2543534
    [Abstract] [Full Text] [Related]

  • 12. Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockade.
    Murray KT, Reilly C, Koshakji RP, Roden DM, Lineberry MD, Wood AJ, Siddoway LA, Barbey JT, Woosley RL.
    J Clin Invest; 1990 Mar; 85(3):836-42. PubMed ID: 2155929
    [Abstract] [Full Text] [Related]

  • 13. Effects of alpha-1-acid glycoprotein administration on propranolol binding and beta blockade in rats.
    Keyler DE, Pentel PR.
    Biochem Pharmacol; 1989 Apr 01; 38(7):1163-8. PubMed ID: 2539818
    [Abstract] [Full Text] [Related]

  • 14. In vivo beta3-adrenergic stimulation of human thermogenesis and lipid use.
    Schiffelers SL, Blaak EE, Saris WH, van Baak MA.
    Clin Pharmacol Ther; 2000 May 01; 67(5):558-66. PubMed ID: 10824635
    [Abstract] [Full Text] [Related]

  • 15. Blockade of cardiac and renal beta-receptors by low dose propranolol in normal subjects. Clues to its antihypertensive effect.
    Davies R, Pickering TG, Morganti A, Wilson M, Laragh JH.
    Br Heart J; 1979 Mar 01; 41(3):331-5. PubMed ID: 34409
    [No Abstract] [Full Text] [Related]

  • 16. Age-related delay in recovery of beta-adrenergic sensitivity after abrupt propranolol withdrawal in rats.
    Teräväinen TL, Buñag RD.
    Mech Ageing Dev; 1992 Mar 15; 63(1):91-103. PubMed ID: 1318480
    [Abstract] [Full Text] [Related]

  • 17. Isoproterenol and propranolol: ability to cross the blood-brain barrier and effects on cerebral circulation in man.
    Olesen J, Hougård K, Hertz M.
    Stroke; 1978 Mar 15; 9(4):344-9. PubMed ID: 209581
    [Abstract] [Full Text] [Related]

  • 18. Steady-state pharmacokinetics of propranolol enantiomers in healthy male volunteers.
    Paradiso-Hardy FL, Walker SE, Bowles SK.
    Int J Clin Pharmacol Ther; 1998 Jul 15; 36(7):370-5. PubMed ID: 9707351
    [Abstract] [Full Text] [Related]

  • 19. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration.
    Aarons RD, Nies AS, Gal J, Hegstrand LR, Molinoff PB.
    J Clin Invest; 1980 May 15; 65(5):949-57. PubMed ID: 6102572
    [Abstract] [Full Text] [Related]

  • 20. Dual adrenergic control of renin during nonhypotensive hemorrhage in conscious dogs.
    Blair ML, Hisa H, Sladek CD, Radke KJ, Gengo FM.
    Am J Physiol; 1991 Jun 15; 260(6 Pt 1):E910-9. PubMed ID: 1647672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.